Physician profile
Abesh Niroula
NPI 1871856468
$12,525.08
in general payments reported to CMS, 2019-2025
10 companies · $1,232 in 2025
The $1,232 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $302 · 2022: $3,017 · 2023: $6,675 · 2024: $659 · 2025: $1,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,631 · Travel and Lodging: $3,186 · Education: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,631.45 |
| Travel and Lodging | $3,185.63 |
| Education | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,125.87 | 2022-2025 | Da Vinci Surgical System |
| Pinnacle Biologics, INC | $4,439.78 | 2023-2025 | Photofrin |
| Pulmonx Corporation | $1,383.56 | 2023-2024 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Boston Scientific Corporation | $848.05 | 2019-2020 | |
| Noah Medical Corporation | $387.12 | 2023-2025 | Galaxy |
| Olympus Corporation of The Americas | $92.96 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $80.38 | 2023 | Lynparza |
| Glaxosmithkline, LLC. | $60.49 | 2025 | |
| Olympus America INC. | $58.07 | 2024 | Spiration Valve System |
| Ambu INC. | $48.80 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abesh Niroula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.